Bulk Orders 20+ bottles
Volume pricing applies automatically from three bottles and reaches 20% at twenty. Larger runs, institutional supply and custom timelines get a quote.
Ask about bulk
Dermal Interface Products
PP405 is a follicle-focused research liquid supplied at 15MG/ML in a 30ML bottle, providing 450MG total PP405 content.
Bundle & save
Referral program · researchers save 10%, you earn 15% backThe compounds researchers order most, by verified order volume.
More ways to save
Volume pricing applies automatically from three bottles and reaches 20% at twenty. Larger runs, institutional supply and custom timelines get a quote.
Ask about bulkVerified test results
Each batch is analyzed by Freedom Diagnostics, an independent third-party laboratory, before release. Below is the report for lot PP01, summarized from the certificate the lab published.
This lot ships under its own published certificate. Open any certificate below, exactly as the lab released it.
Side by side
Important research notice
Not for human, veterinary, or food use. This product is sold exclusively for laboratory research purposes. It is not intended to diagnose, treat, cure, or prevent any disease, and has not been evaluated by the FDA.
All referenced publications and registries are sourced from peer-reviewed journals and official registries. They are provided for educational reference only and are not product claims.
By purchasing, you confirm you are a qualified researcher and will handle this product in accordance with all applicable laws and regulations.
Ready when you are
The lot on this page links to the signed certificate for that batch.
PP405 is a premium follicle-focused research liquid supplied at 15MG/ML in a 30ML bottle, providing 450MG total PP405 content. PP405 is studied in controlled laboratory investigations involving hair-follicle stem-cell metabolism research, mitochondrial pyruvate carrier pathway models, lactate dehydrogenase-associated signaling, follicular microenvironment studies, cellular energy-pathway research, and follicle-cycle pathway investigations.
Disguised Alpha PP405 is supplied as a finished follicle research liquid for laboratories requiring clear concentration labeling, total-content transparency, clean bottle presentation, documentation support, internal QA review, and direct in-house fulfillment.
Compound: PP405
Concentration: 15MG/ML
Total Volume: 30ML
Total Content: 450MG PP405
Format: Follicle research liquid
Research Category: Hair-follicle stem-cell / MPC / LDH pathway research
Research Focus: Hair-follicle stem-cell metabolism research, mitochondrial pyruvate carrier pathway models, lactate dehydrogenase-associated signaling, follicular microenvironment studies, cellular energy-pathway research, and follicle-cycle pathway investigations.
PP405 is studied in controlled research models involving mitochondrial pyruvate carrier pathway behavior, LDH-associated metabolic signaling, hair-follicle stem-cell activity, follicular microenvironment response systems, and cellular energy-state research.
Studied in models involving mitochondrial pyruvate carrier signaling, pyruvate-handling pathways, cellular metabolism, and energy-state response systems.
Relevant to controlled investigations involving lactate dehydrogenase-associated signaling, lactate-linked metabolic research, and follicular stem-cell pathway studies.
Supplied as a clearly labeled 15MG/ML follicle research liquid with 30ML total volume and 450MG total PP405 content.
PP405 is studied in laboratory models involving hair-follicle stem-cell metabolism, mitochondrial pyruvate carrier pathway behavior, lactate dehydrogenase-associated signaling, cellular energy-state regulation, follicular microenvironment response systems, and follicle-cycle pathway research.
Research interest in PP405 centers on how follicle-associated metabolic pathway compounds may be evaluated in models involving pyruvate handling, lactate-linked cellular signaling, follicular stem-cell activity, and energy-metabolism response systems under controlled laboratory conditions.
Finished liquid research products require more oversight than a basic compound listing. Concentration clarity, formula consistency, total-content transparency, solution appearance, documentation, label review, storage expectations, packaging quality, and fulfillment handling all matter.
Disguised Alpha reviews PP405 as a complete follicle research liquid with attention to 15MG/ML concentration presentation, 30ML bottle format, 450MG total-content clarity, product documentation, internal QA, labeling accuracy, and direct fulfillment accountability.
We believe researchers should be able to verify the standards we speak about. Learn more about the independent laboratories we work with below.
Visit ILS LabsDisguised Alpha is built around direct accountability. Every order is processed, inspected, packaged, and shipped by our in-house team instead of being passed off to a third-party logistics warehouse.
This gives us tighter control over formulation quality, fulfillment accuracy, packaging standards, storage conditions, and customer experience. Our goal is not to be the cheapest research supplier. It is to provide professionally handled compounds with real quality oversight behind them.
Research Use Disclaimer:No. PubChem lists PP405, JXL069 and suvomipic as names for one small molecule, (E)-3-[1-[[3,5-bis(trifluoromethyl)phenyl]methyl]pyrrolo[2,3-b]pyridin-3-yl]-2-cyanoprop-2-enoic acid, C₂₀H₁₁F₆N₃O₂ at 439.3 g/mol, which has no amino acids or peptide bonds. UCLA chemists described JXL069 in 2021 as an analog of UK-5099, an inhibitor of the mitochondrial pyruvate carrier.
Under the code JXL069, which PubChem lists for the same structure, it inhibits the mitochondrial pyruvate carrier, the MPC1 and MPC2 complex that moves pyruvate into mitochondria: in permeabilized human MCF10A breast epithelial cells, JXL069 blocked pyruvate-fueled respiration with an IC50 of 42.8 nM. A PubMed search for PP405 on 15 October 2026 returned one record, a 2026 review.
Yes. As of 15 October 2026, ClinicalTrials.gov lists two Pelage Pharmaceuticals studies: a randomized, multicenter, double-blind, vehicle-controlled phase 2a study in 78 adults with androgenetic alopecia (NCT06393452), status "Completed", and a randomized, multicenter, double-blind, vehicle-controlled phase 2/3 study in an estimated 600 adult males with androgenetic alopecia (NCT07819435), status "Recruiting". Drugs@FDA lists no product containing PP405.
This page sells PP405 as a research liquid supplied at 15MG/ML in a 30ML bottle, providing 450MG total PP405 content, and its lot's certificate, from Freedom Diagnostics, is shown on the page. It is sold exclusively for laboratory research purposes, not for human, veterinary, or food use, and ships from Irvine, California, by FedEx 2-Day shipping.
Match the selected product option and assigned shipping lot to the corresponding report in the COA portal. Check the compound or components, sample identification, test date, methods and results actually reported. Results for another lot or formulation are not a substitute.
No. Analytical purity and measured content are different measurements. Compare labeled quantity with measured content only where the report provides a compatible result and unit.
Read the PP405 (MPC Follicle Inhibitor) research reference or explore PP405 clinical trials and the 2026 AWAKEN update. For batch documentation or formulation questions, contact Disguised Alpha.
PP405 is a follicle-focused research liquid supplied at 15MG/ML in a 30ML bottle, providing 450MG total PP405 content.
The current certificate is matched to the selected product option and assigned shipping batch.
Enable JavaScript to view the certificate for your selected option.